Characterization of Desmoglein Expression in the Normal Prostatic Gland. Desmoglein 2 Is an Independent Prognostic Factor for Aggressive Prostate Cancer

• Alison G. Barber,

  Affiliation Department of Genetics and Development, Columbia University, New York, New York, United States of America

  ⨯
• Mireia Castillo-Martin ,

  * E-mail: mireia.castillo-martin@mssm.edu (MCM); carlos.cordon-cardo@mssm.edu (CCC)

  Affiliation Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America

  ⨯
• Dennis M. Bonal,

  Affiliation Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America

  ⨯
• Benjamin A. Rybicki,

  Affiliation Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, United States of America

  ⨯
• Angela M. Christiano,

  Affiliations Department of Genetics and Development, Columbia University, New York, New York, United States of America, Department of Dermatology, Columbia University, New York, New York, United States of America

  ⨯
• Carlos Cordon-Cardo

  * E-mail: mireia.castillo-martin@mssm.edu (MCM); carlos.cordon-cardo@mssm.edu (CCC)

  Affiliations Department of Pathology and Cell Biology, Columbia University, New York, New York, United States of America, Department of Urology, Columbia University, New York, New York, United States of America, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York, United States of America, Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America

  ⨯